In the wake of a big data breach and a sizable new round of layoffs, 23andMe's troubles have some people looking to delete ...
Amid its plummeting stock value, layoffs and cuts to its drug R&D program, the battered company is carrying on.
Me, a major company providing direct-to-consumer genetic testing, has been struggling financially since late 2023. In ...
Me, a major company providing direct-to-consumer genetic testing, has been struggling financially since late 2023. In September 2024, the ...
It was a simple process. You’d collect a saliva sample, ship it off, and within six weeks, you’d receive a complete ancestral ...
U.S. District Judge Edward Chen, of the Northern District of California, preliminary approved the 23andMe settlement, ...
No. 23andMe is considered a direct-to-consumer genetic testing company, and transactions with the company are considered ...
Johns Hopkins researchers have developed a powerful new AI tool called "Splam" that can identify where splicing occurs in ...
From an air fryer to a Wordle board game, these under-$30 Walmart picks are the ultimate crowd-pleasers. Black Friday may be ...
A federal judge granted early approval to a $30 million settlement to resolve claims 23andMe Inc. failed to protect the ...
"There's no one perfect or best way to measure biological age," Koelsch says. "I like to think of it as like having a car.
The restructuring arrives during a period of turmoil at 23andMe, which has recently included a high-profile data breach and several rounds of previous layoffs.